肝细胞癌中的免疫检查点和治疗耐药性的挑战

Xin Tao1, Xiaoxia Yang1

  • 1Department of Infectious Disease, Heping Hospital, Affiliated to Changzhi Medical College, Changzhi, Shanxi Province, China.

概括

免疫检查点抑制剂 (ICI) 对肝细胞癌 (HCC) 是有前途的,但却面临抗药性. 本综述探讨了ICI耐药机制和新疗法,以改善HCC患者的治疗结果.

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K